Literature DB >> 9392419

Post-translational regulation of mevalonate kinase by intermediates of the cholesterol and nonsterol isoprene biosynthetic pathways.

D D Hinson1, K L Chambliss, M J Toth, R D Tanaka, K M Gibson.   

Abstract

To assess the potential for feedback inhibition by isoprene intermediates in the cholesterol and nonsterol isoprene biosynthetic pathway, we expressed human cDNAs encoding mevalonate kinase (MKase), phosphomevalonate kinase (PMKase), and mevalonate diphosphate decarboxylase (MDDase) as fusion proteins in Escherichia coli DH5alpha, and purified these proteins by affinity chromatography. Several phosphorylated and non-phosphorylated isoprenes were analyzed as inhibitors of the enzymes using a standard spectrophotometric assay. Of the three proteins, only MKase was inhibited through competitive interaction at the ATP-binding site. The intermediates studied (and their relative inhibitory capacity) were: geranylgeranyl-diphosphate (GGPP, C20) > farnesyl-diphosphate (FPP, C15) > geranyl-diphosphate (GPP, C10) > isopentenyl-diphosphate (IPP, C5) > or = 3,3-dimethylallyl-diphosphate (DMAPP, C5) > farnesol (C15) > dolichol-phosphate (DP, C(80-100)). Mevalonate-diphosphate, geraniol, and dolichol were not inhibitors. Our data further define the spectrum of physiologic inhibitors of MKase, and provide the first evidence for feedback inhibition of MKase by a nonsterol isoprene produced by the branched pathway, dolichol-phosphate. These results provide additional evidence that MKase may occupy a central regulatory role in the control of cholesterol and nonsterol isoprene biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9392419

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  39 in total

Review 1.  Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway.

Authors:  Annalisa Marcuzzi; Elisa Piscianz; Claudia Loganes; Liza Vecchi Brumatti; Alessandra Knowles; Sabrine Bilel; Alberto Tommasini; Roberta Bortul; Marina Zweyer
Journal:  Int J Mol Sci       Date:  2015-12-30       Impact factor: 5.923

2.  Dexamethasone-induced decrease in HMG-CoA reductase and protein-farnesyl transferase activities does not impair ras processing in AR 4-2J cells.

Authors:  M Lambert; N D Bui
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

3.  Bisphosphonate-Generated ATP-Analogs Inhibit Cell Signaling Pathways.

Authors:  Satish R Malwal; Bing O'Dowd; Xinxin Feng; Petri Turhanen; Christopher Shin; Jiaqi Yao; Boo Kyung Kim; Noman Baig; Tianhui Zhou; Sandhya Bansal; Rahul L Khade; Yong Zhang; Eric Oldfield
Journal:  J Am Chem Soc       Date:  2018-06-05       Impact factor: 15.419

4.  Molecular cloning and expression analysis of the mevalonate kinase gene from Arabidopsis thaliana.

Authors:  M A Lluch; A Masferrer; M Arró; A Boronat; A Ferrer
Journal:  Plant Mol Biol       Date:  2000-01       Impact factor: 4.076

5.  Characterization of a feedback-resistant mevalonate kinase from the archaeon Methanosarcina mazei.

Authors:  Yuliya A Primak; Mai Du; Michael C Miller; Derek H Wells; Alex T Nielsen; Walter Weyler; Zachary Q Beck
Journal:  Appl Environ Microbiol       Date:  2011-09-09       Impact factor: 4.792

6.  Mevalonate analogues as substrates of enzymes in the isoprenoid biosynthetic pathway of Streptococcus pneumoniae.

Authors:  Takashi Kudoh; Chan Sun Park; Scott T Lefurgy; Meihao Sun; Theodore Michels; Thomas S Leyh; Richard B Silverman
Journal:  Bioorg Med Chem       Date:  2009-12-24       Impact factor: 3.641

7.  Human mevalonate diphosphate decarboxylase: characterization, investigation of the mevalonate diphosphate binding site, and crystal structure.

Authors:  Natalia E Voynova; Zhuji Fu; Kevin P Battaile; Timothy J Herdendorf; Jung-Ja P Kim; Henry M Miziorko
Journal:  Arch Biochem Biophys       Date:  2008-09-18       Impact factor: 4.013

8.  Deletion of a single mevalonate kinase (Mvk) allele yields a murine model of hyper-IgD syndrome.

Authors:  E J Hager; H M Tse; J D Piganelli; M Gupta; M Baetscher; T E Tse; A S Pappu; R D Steiner; G F Hoffmann; K M Gibson
Journal:  J Inherit Metab Dis       Date:  2007-11-19       Impact factor: 4.982

9.  Functional evaluation of conserved basic residues in human phosphomevalonate kinase.

Authors:  Timothy J Herdendorf; Henry M Miziorko
Journal:  Biochemistry       Date:  2007-09-29       Impact factor: 3.162

10.  Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion.

Authors:  William B Rizzo; Dana S'Aulis; M Anitia Jennings; Debra A Crumrine; Mary L Williams; Peter M Elias
Journal:  Arch Dermatol Res       Date:  2010-01-05       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.